M Bayes, X Rabasseda, JR Prous - Methods and findings in experimental and clinical …, 2006 - journals.prous.com Contributing Editors: P. Cole, C. Orellana, JA Vallès, RM a . Antonijoan, KP
Mohana Priya, M. Priya, V. Renuga, R. Sree Lekha, B. Priya, A. Tomillero, G.
Krithiga and E. Banu Rekha. Cited by 148 - Related articles - All 9 versions
S Garg, J Rosenstock, BL Silverman, B Sun, … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 891–899 DOI 10.1007/s00125-006-0161-3 ARTICLE S.
Garg . J. Rosenstock . BL Silverman . B. Sun . CS Konkoy . A. de la Peña . ... Cited by 61 - Related articles - BL Direct - All 5 versions
ES Khafagy, M Morishita, Y Onuki, K … - Advanced Drug Delivery Reviews, 2007 - Elsevier The quest to eliminate the needle from insulin delivery and to replace it with
non- or less-invasive alternative routes has driven rigorous pharmaceutical
research to replace the injectable forms of insulin. Recently, various ... Cited by 32 - Related articles - All 3 versions
- ►nih.gov R Vehring - Pharmaceutical Research, 2008 - Springer Received August 30, 2007; accepted October 9, 2007; published online November
28, 2007 Abstract. This review covers recent developments in the area of
particle engineering via spray drying. The last decade has seen a shift ... Cited by 20 - Related articles - All 4 versions
DB Muchmore, JR Gates - Diabetes Obesity and Metabolism, 2006 - interscience.wiley.com Since 1925, when the concept of treating diabetes with inhaled insulin (INH) was
originally published, a number of clinical challenges have been resolved through
technological advancements. Efforts by pharmaceutical partnerships or ... Cited by 15 - Related articles - BL Direct - All 4 versions
N Sadrzadeh, MJ Glembourtt, CL Stevenson - Journal of pharmaceutical sciences, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 15 - Related articles - BL Direct - All 4 versions
R Jani, C Triplitt, C Reasner, RA DeFronzo - Expert Opin. Drug Deliv., 2007 - informahealthcare.com The long-term benefits of tight glycemic control in preventing microvascular and
macrovascular complications are well established in both Type 1 diabetes
mellitus (Type 1 DM) and Type 2 diabetes mellitus (Type 2 DM). Nonetheless, ... Cited by 12 - Related articles - BL Direct - All 6 versions
VP Guntur, R Dhand - Respiratory care, 2007 - rtjournalonline.com Targeted glycemic control in patients with type 1 and type 2 diabetes is grossly
inadequate, despite data demonstrating reduced microvascular and macrovascular
diabetic complications with inten- sive treatment. A significant proportion ... Cited by 11 - Related articles - View as HTML - BL Direct - All 5 versions
PA Hollander - Medscape General Medicine, 2007 - pubmedcentral.nih.gov Many patients with diabetes fail to meet recommended glycemic goals regardless
of the recognition of optimal glycemic control as a key component for improving
clinical outcomes and quality of life in patients with diabetes. Patient- ... Cited by 11 - Related articles - All 4 versions
